TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$65.12
1.25 (1.96%)
▲
5d:
+16.1%
30d:
+35.5%
90d:
+163.86%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TXG is 13.5% above its trading range ($57.35). Market expects 27.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TXG is 13.5% above its trading range ($57.35). Market expects 27.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.90
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $65.12, which is considered extended relative to its 30-day fair value range of $44.19 to $57.35. From a valuation perspective, the stock is trading at a premium (Forward PE: 320.3) compared to its historical average (155.1). At these levels, the market is pricing in 27.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. The price is approaching resistance at $65.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TXG scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $49.54. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXG is in a strong uptrend. The price is approaching resistance at $65.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TXG scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $49.54. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.19 -
$57.35
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
4.8%
All Signals
- BEARISH: Price significantly overextended (+13.5% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 23.9% above Wall St target ($49.54)
- BEARISH: Market expects 27.4% growth - appears too optimistic based on history
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$44.19 -
$57.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$50.81
Resistance Level
$65.47
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
320.31
Wall Street Target
$49.54
(-23.9%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+27.4% premium
PE vs Historical
320.3 vs 155.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+27.4%
(market-implied from PE analysis)
1-Year Target
$82.96
(+27%)
2-Year Target
$105.69
(+62%)
3-Year Target
$134.66
(+107%)
3-Yr Target (if PE normalizes)
(PE: 320→155)
PE COMPRESSION
$65.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 320.3, Growth: 93.6%)
$219.78
(+238%)
Base:
(SPY PE: 20.1, Growth: 93.6%)
$13.77
(-79%)
Bear:
(PE: 17.1, Growth: 93.6%)
$11.71
(-82%)
Share & Embed Analysis
Last updated: August 22, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM
Data refreshes hourly during market hours. Next update: 5:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |
